| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 5.448 | 22.045 | 48.687 | 55.179 | 54.588 | 61.772 | 65.437 |
| Total Income - EUR | - | - | 0 | 9.684 | 27.565 | 54.289 | 80.294 | 54.588 | 61.778 | 65.437 |
| Total Expenses - EUR | - | - | 110 | 32.297 | 36.333 | 38.868 | 45.197 | 36.585 | 40.211 | 47.639 |
| Gross Profit/Loss - EUR | - | - | -110 | -22.613 | -8.768 | 15.421 | 35.097 | 18.004 | 21.567 | 17.799 |
| Net Profit/Loss - EUR | - | - | -110 | -22.668 | -8.990 | 14.934 | 34.545 | 17.458 | 20.949 | 15.836 |
| Employees | - | - | 0 | 3 | 3 | 3 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Rainbow Eye Oftaclinic S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 66 | 39.251 | 33.027 | 26.814 | 20.473 | 27.923 | 21.685 | 16.225 |
| Current Assets | - | - | 35 | 181 | 4.363 | 11.276 | 4.008 | 6.085 | 7.275 | 7.312 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 0 | 473 | 0 | 0 | 5.737 | 0 |
| Cash | - | - | 35 | 181 | 4.363 | 10.803 | 4.008 | 6.085 | 1.538 | 7.312 |
| Shareholders Funds | - | - | -66 | -22.732 | -31.282 | -15.754 | 19.140 | 20.649 | 20.998 | 15.884 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 167 | 62.164 | 68.672 | 53.844 | 5.341 | 13.359 | 7.962 | 7.653 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Rainbow Eye Oftaclinic S.r.l.